Predictors of survival in oesophageal cancer patients in a high-risk area in Northern Iran: the role of health services utilisation
G. Golalipour MD
Research Fellow
Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
Search for more papers by this authorS. Semnani MD
Associate Professor
Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
Search for more papers by this authorB. Safaie MD
Assistant Professor
Department of Pathology, Golestan University of Medical Sciences, Gorgan, Iran
Search for more papers by this authorS. Rajaie MD
Assistant Professor
Department of Surgery, Golestan University of Medical Sciences, Gorgan, Iran
Search for more papers by this authorS.M. Sedaghat MD
Health Service Manager
Department of Health, Golestan University of Medical Sciences, Gorgan, Iran
Search for more papers by this authorH.R. Kamalinia MD
Health Service Manager
Department of Health, Golestan University of Medical Sciences, Gorgan, Iran
Search for more papers by this authorM. Aarabi MD, PhD
Assistant Professor
Health Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran
Search for more papers by this authorCorresponding Author
G. Roshandel MD, PhD
Assistant Professor
Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
Correspondence
Dr Gholamreza Roshandel, Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
Email: [email protected]
Search for more papers by this authorG. Golalipour MD
Research Fellow
Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
Search for more papers by this authorS. Semnani MD
Associate Professor
Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
Search for more papers by this authorB. Safaie MD
Assistant Professor
Department of Pathology, Golestan University of Medical Sciences, Gorgan, Iran
Search for more papers by this authorS. Rajaie MD
Assistant Professor
Department of Surgery, Golestan University of Medical Sciences, Gorgan, Iran
Search for more papers by this authorS.M. Sedaghat MD
Health Service Manager
Department of Health, Golestan University of Medical Sciences, Gorgan, Iran
Search for more papers by this authorH.R. Kamalinia MD
Health Service Manager
Department of Health, Golestan University of Medical Sciences, Gorgan, Iran
Search for more papers by this authorM. Aarabi MD, PhD
Assistant Professor
Health Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran
Search for more papers by this authorCorresponding Author
G. Roshandel MD, PhD
Assistant Professor
Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
Correspondence
Dr Gholamreza Roshandel, Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
Email: [email protected]
Search for more papers by this authorAbstract
We aimed to determine predictors of survival in oesophageal cancer (EC) patients in a high-risk area. This study was conducted on EC patients diagnosed in 2007–2008 in Golestan province, Iran. Diagnostic (DU) and Therapeutic (TU) services utilisation indices were determined. DU and TU indices of 1 were considered as good utilisation. EC-specific survival rates were calculated. Multivariate Cox-regression model was used to calculate adjusted hazard ratios (AHRs). Two hundred and twenty-three EC subjects were enrolled. The median survival time was 10.47 months and the 5-year survival rate was 11%. Cox-regression analysis suggested that stage of tumour (AHRregional = 3.75, 95% confidence interval [CI]: 2.34–6.00; AHRmetastasis = 12.21, 95% CI: 7.42–20.08) and TU (AHR = 1.78, 95% CI: 1.25–2.52) were the strongest variables related to EC survival. The median survival time in patients with good and poor TU were 14.37 and 8.53 months respectively (p < .01). There was no significant relationship between DU and EC survival. We found relatively low survival rates in our EC patients when compared with developed countries. Our results also suggested an increasing trend for EC survival rate during recent years. Good TU could predict higher survival rates. Patients' access to therapeutic services may be considered as an important indicator in decision-making for controlling EC.
References
- Abdullah, M., Karim, A. A., & Goh, K. L. (2010). Late presentation of esophageal cancer: Observations in a multiracial South-East Asian population. Journal of Digestive Diseases, 11, 28–33.
- Aghcheli, K., Marjani, H.-A., Nasrollahzadeh, D., Islami, F., Shakeri, R., Sotoudeh, M., … & Khalilipour, E. (2011). Prognostic factors for esophageal squamous cell carcinoma—A population-based study in Golestan Province, Iran, a high incidence area. PLoS ONE, 6, e22152.
- Alidina, A., Gaffar, A., Hussain, F., Islam, M., Vaziri, I., Burney, I., … & Jafri, W. (2004). Survival data and prognostic factors seen in Pakistani patients with esophageal cancer. Annals of Oncology, 15, 118–122.
- Bernardes, C. M., Whop, L. J., Garvey, G., & Valery, P. C. (2012). Health service utilization by indigenous cancer patients in Queensland: A descriptive study. International Journal for Equity in Health, 11, 57.
- Coory, M. D., Green, A. C., Stirling, J., & Valery, P. C. (2008). Survival of Indigenous and non-Indigenous Queenslanders after a diagnosis of lung cancer: A matched cohort study. The Medical Journal of Australia, 188, 562–566.
- Cramb, S. M., Garvey, G., Valery, P. C., Williamson, J. D., & Baade, P. D. (2012). The first year counts: Cancer survival among Indigenous and non-Indigenous Queenslanders, 1997–2006. The Medical Journal of Australia, 196, 270–274.
- DeSantis, C. E., Lin, C. C., Mariotto, A. B., Siegel, R. L., Stein, K. D., Kramer, J. L., … & Jemal, A. (2014). Cancer treatment and survivorship statistics, 2014. CA: A Cancer Journal for Clinicians, 64, 252–271.
- Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., … & Bray, F. (2013). GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer.
- Ferrante, J. M., Lee, J. H., McCarthy, E. P., Fisher, K. J., Chen, R., Gonzalez, E. C., … & Roetzheim, R. G. (2013). Primary care utilization and colorectal cancer incidence and mortality among Medicare beneficiaries: A population-based, case-control study. Annals of Internal Medicine, 159, 437–446.
- Harirchi, I., Kolahdoozan, S., Hajizadeh, S., Safari, F., Sedighi, Z., Nahvijou, A., … & Zendehdel, K. (2014). Esophageal cancer in Iran; a population-based study regarding adequacy of cancer surgery and overall survival. European Journal of Surgical Oncology, 40, 352–357.
- Islami, F., Kamangar, F., Nasrollahzadeh, D., Moller, H., Boffeta, P., & Malekzadeh, R. (2009). Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran – A review. European Journal of Cancer, 45, 3156–3165.
- Lu, X. J., Chen, Z. F., Guo, C. L., Li, S. S., Bai, W. L., Jin, G. L., … & Hou, J. (2004). Endoscopic survey of esophageal cancer in a high-risk area of China. World Journal of Gastroenterology, 10, 2931–2935.
- Mahboubi, E., Kmet, J., Cook, P. J., Day, N. E., Ghadirian, P., & Salmasizadeh, S. (1973). Oesophageal cancer studies in the Caspian Littoral of Iran: The Caspian cancer registry. British Journal of Cancer, 28, 197–214.
- Mir, M. R., Rajabpour, M. V., Delarestaghi, M. M., Hadji, M., Harirchi, I., Mir, P., … & Zendehdel, K. (2013). Short- and long-term survival of esophageal cancer patients treated at the Cancer Institute of Iran. Digestive Surgery, 30, 331–336.
- Roshandel, G., Khoshnia, M., Sotoudeh, M., Merat, S., Etemadi, A., Nickmanesh, A., … & Malekzadeh, R. (2014). Endoscopic screening for precancerous lesions of the esophagus in a high risk area in Northern Iran. Archives of Iranian Medicine, 17, 246–252.
- Roshandel, G., Majdzadeh, R., Keshtkar, A., Aramesh, K., Sedaghat, S. M., & Semnani, S. (2011). Healthcare utilization in patients with esophageal cancer in a high risk area in northeast of Iran. Asian Pacific Journal of Cancer Prevention, 12, 2437–2442.
- Roshandel, G., Merat, S., Sotoudeh, M., Khoshnia, M., Poustchi, H., Lao-Sirieix, P., … & Malekzadeh, R. (2014). Pilot study of cytological testing for oesophageal squamous cell dysplasia in a high-risk area in Northern Iran. British Journal of Cancer, 111, 2235–2241.
- Roshandel, G., Sadjadi, A., Aarabi, M., Khademi, H., Keshtkar, A., Sedaghat, S. M., … & Malekzadeh, R. (2012). Cancer incidence in Golestan: Report of an ongoing population-based cancer registry in Iran, 2004–2008. Archives of Iranian Medicine, 15, 196–200.
- Samadi, F., Babaei, M., Yazdanbod, A., Fallah, M., Nouraie, M., Nasrollahzadeh, D., … & Malekzadeh, R. (2007). Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Archives of Iranian Medicine, 10, 32–37.
- Semnani, S., Besharat, S., Kashtkar, A., Danesh, A., Abdolahi, N., Roshandel, G., … & Sedaghat, M. (2008). Short-term survival rates of upper gastrointestinal cancers in rural areas of Golestan province, Iran. Journal of Gorgan University of Medical Sciences, 10, 51–57.
- Semnani, S., Sadjadi, A., Fahimi, S., Nouraie, M., Naeimi, M., Kabir, J., … & Malekzadeh, R. (2006). Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: A retrospective cancer surveillance. Cancer Detection and Prevention, 30, 14–19.
- Shahbaz Sarwar, C. M., Luketich, J. D., Landreneau, R. J., & Abbas, G. (2010). Esophageal cancer: An update. International Journal of Surgery, 8, 417–422.
- Yarhusseini, A., Sharifzadeh, L., Delpisheh, A., Veisani, Y., Sayehmiri, F., & Sayehmiri, K. (2014). Survival rate of esophageal carcinoma in Iran – A systematic review and meta-analysis. Iranian Journal of Cancer Prevention, 7, 61–65.
- Yim, J., Hwang, S.-s., Yoo, K.-y., & Kim, C.-y. (2012). Contribution of income-related inequality and healthcare utilisation to survival in cancers of the lung, liver, stomach and colon. Journal of Epidemiology and Community Health, 66, 37–40.
- Young, J., Jr., Roffers, S., Ries, L., Fritz, A., & Hurlbut, A. (2001). SEER summary staging manual-2000: Codes and coding instructions. Bethesda, MD: National Cancer Institute.
- Zhang, Y. (2013). Epidemiology of esophageal cancer. World Journal of Gastroenterology, 19, 5598–5606.
